Skip to main content
Psychiatry
ALL Specialities
ALL Specialities
/
Psychiatry
COVID-19 Updates
News
From the Journals
FDA/CDC
Guidelines
Feature
Latest News
News by Conference
News from the FDA/CDC
Perspectives
Commentary
Curbside Consult
Families in Psychiatry
For Residents
From the Editor
Interview
Mental Health Consult
Shrink Rap News
Techiatry
Weighty Issues
Supplements
Reviews
Cases That Test Your Skills
Clinical Neuroscience
Evidence-Based Reviews
Med/Psych Update
Out of the Pipeline
Pearls
Savvy Psychopharmacology
CME
CME Supplements
Medical Education Library
Diseases and Conditions
Addiction Medicine
ADHD
Alzheimer's & Cognition
Anxiety Disorders
Bipolar Disorder
Depression
Eating Disorders
Movement Disorders
Personality Disorders
PTSD
Schizophrenia & Other Psychotic Disorders
Sleep Medicine
Somatic Disorders
Multimedia
Podcasts
Video
Resource Center
Lifestyle
Conference Coverage
New BACE1 study launches in the shadow of verubecestat’s demise
Publish date:
November 4, 2017
AT CTAD
msullivan@frontlinemedcom.com
On Twitter
@Alz_Gal
Pages
« first
1
2
Recommended Reading
Fueling the Alzheimer’s brain with fat
MDedge Psychiatry
Study linked H2 receptor antagonists, but not PPIs, to dementia
MDedge Psychiatry
Higher BP targets suggested for elderly, cognitively impaired
MDedge Psychiatry
Personality changes may not occur before Alzheimer’s onset
MDedge Psychiatry
APOE affects tau pathology independent of amyloid-beta
MDedge Psychiatry
VIDEO: Alzheimer’s blood test expected soon
MDedge Psychiatry
Lumateperone shows broad phase 3 potential for psychiatric disorders
MDedge Psychiatry
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
MDedge Psychiatry
In Lewy body disease, CSF may reveal dementia risk
MDedge Psychiatry
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
MDedge Psychiatry
Alzheimer's & Cognition
Neurology
Geriatrics
All Specialties
